title: Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Athyros
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Asterios
authors.initials: A
authors.lastname: Karagiannis
mesh_terms: D000367:Age Factors; D017311:Amlodipine / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D004338:Drug Combinations; D005234:Fatty Liver / Q000188:drug therapy; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy; D065626:Non-alcoholic Fatty Liver Disease; D010349:Patient Compliance; D011758:Pyrroles / Q000627:therapeutic use*; D012306:Risk; D040242:Risk Reduction Behavior
chemical_list: D000959:Antihypertensive Agents; D008078:Cholesterol, LDL; D004338:Drug Combinations; D006538:Heptanoic Acids; D011758:Pyrroles; C487936:amlodipine, atorvastatin drug combination; D017311:Amlodipine